Acute Myeloid Leukaemia Recurrent
also: Acute Myeloid Leukemia Recurrent
4 drugs356 FAERS reportsMedDRA PT
GET
/api/v1/reaction/acute-myeloid-leukaemia-recurrentReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Acute Myeloid Leukaemia Recurrent (4)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Omidubicel15.6%
- 2Daunorubicin1724.7%
- 3Gilteritinib1694.5%
- 4Quizartinib142.5%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Acute Myeloid Leukaemia3 shared · 0.11
- Myelosuppression3 shared · 0.06
- Electrocardiogram Qt Prolonged2 shared · 0.06
- Septic Shock2 shared · 0.04
- Infection3 shared · 0.02
- White Blood Cell Count Decreased2 shared · 0.02
- Pancytopenia2 shared · 0.02
- Platelet Count Decreased3 shared · 0.02
- Febrile Neutropenia3 shared · 0.02
- Product Use Issue2 shared · 0.01
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.